Ignite Creation Date:
2025-12-25 @ 4:34 AM
Ignite Modification Date:
2026-01-17 @ 11:18 AM
Study NCT ID:
NCT01786018
Status:
UNKNOWN
Last Update Posted:
2014-07-08
First Post:
2013-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas
Sponsor:
Azienda Ospedaliera San Giovanni Battista
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B-cell Lymphoma Refractory | View |